These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 33901133)

  • 1. Levetiracetam-Associated Obsessive-Compulsive Symptoms in a Preschooler.
    Yumnam S; Bhagwat C; Saini L; Sharma A; Shah R
    J Clin Psychopharmacol; 2021 Jul-Aug 01; 41(4):495-496. PubMed ID: 33901133
    [No Abstract]   [Full Text] [Related]  

  • 2. Obsessive-compulsive behavior induced by levetiracetam.
    Fujikawa M; Kishimoto Y; Kakisaka Y; Jin K; Kato K; Iwasaki M; Nakasato N
    J Child Neurol; 2015 Jun; 30(7):942-4. PubMed ID: 25008911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levetiracetam-Through a Psychiatric Prism.
    Naguy A
    Prim Care Companion CNS Disord; 2019 Nov; 21(6):. PubMed ID: 31751502
    [No Abstract]   [Full Text] [Related]  

  • 4. Levetiracetam Induced Neuropsychiatric Manifestation in a 5-year-old Boy.
    Kathiravan M ; Dhawan SR; Singanamala B; Saini L; Sahu JK
    Indian J Pediatr; 2019 Feb; 86(2):193. PubMed ID: 30209735
    [No Abstract]   [Full Text] [Related]  

  • 5. Factors associated with obsessive-compulsive symptoms in people with epilepsy.
    Kim SJ; Lee SA; Ryu HU; Han SH; Lee GH; Jo KD; Kim JB
    Epilepsy Behav; 2020 Jan; 102():106723. PubMed ID: 31805509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of Levetiracetam Monotherapy in Pediatric Patients With Epilepsy.
    Mazur RD; Wang Ba Q; Kato Bs K; Buchsbaum Bs R; Bonito Bs J; Choi H; Hirsch L; Detyniecki K
    J Child Neurol; 2019 Sep; 34(10):593-597. PubMed ID: 31113283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An investigation of the ocular toxic effects of levetiracetam therapy in children with epilepsy.
    Diler Durgut B; Turk A; Acar Arslan E; Kamasak T; Sahin S; Dilber B; Turkcan Soguksulu T; Cansu A
    Childs Nerv Syst; 2019 May; 35(5):769-774. PubMed ID: 30783756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topiramate may induce obsessive-compulsive disorder.
    Thuile J; Even C; Guelfi JD
    Psychiatry Clin Neurosci; 2006 Jun; 60(3):394. PubMed ID: 16732760
    [No Abstract]   [Full Text] [Related]  

  • 9. Co-occurence of blepharospasm, tourettism and obsessive-compulsive symptoms during lamotrigine treatment.
    Alkin T; Onur E; Ozerdem A
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1339-40. PubMed ID: 17537560
    [No Abstract]   [Full Text] [Related]  

  • 10. Lipid and thyroid hormone levels in children with epilepsy treated with levetiracetam or carbamazepine: A prospective observational study.
    Nishiyama M; Takami Y; Ishida Y; Tomioka K; Tanaka T; Nagase H; Nakagawa T; Tokumoto S; Yamaguchi H; Toyoshima D; Maruyama A; Nozu K; Nishimura N; Iijima K
    Epilepsy Behav; 2019 Jan; 90():15-19. PubMed ID: 30500483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levetiracetam-Related Mania-Like Symptoms: An Adolescent Case.
    Ekinci N; Güneş S; Ekinci Ö; Kalinli M; Okuyaz Ç; Direk MÇ
    Clin Neuropharmacol; 2019; 42(3):97-98. PubMed ID: 30829883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Levetiracetam on Cognitive Function and Clonic Seizure Frequency in Children with Epilepsy.
    Zhou S; Zhan Q; Wu X
    Curr Mol Med; 2019; 19(9):699-703. PubMed ID: 31362674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors predisposing to psychotic symptoms during levetiracetam therapy: A retrospective study.
    Pinckaers FME; Boon ME; Majoie MHJM
    Epilepsy Behav; 2019 Nov; 100(Pt A):106344. PubMed ID: 31525554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topiramate related obsessive-compulsive disorder.
    Ozkara C; Ozmen M; Erdogan A; Yalug I
    Eur Psychiatry; 2005 Jan; 20(1):78-9. PubMed ID: 15642451
    [No Abstract]   [Full Text] [Related]  

  • 15. Response of obsessive compulsive disorder to carbamazepine in two patients with comorbid epilepsy.
    Koopowitz LF; Berk M
    Ann Clin Psychiatry; 1997 Sep; 9(3):171-3. PubMed ID: 9339883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction Tools for Psychiatric Adverse Effects After Levetiracetam Prescription.
    Josephson CB; Engbers JDT; Jette N; Patten SB; Singh S; Sajobi TT; Marshall D; Agha-Khani Y; Federico P; Mackie A; Macrodimitris S; McLane B; Pillay N; Sharma R; Wiebe S
    JAMA Neurol; 2019 Apr; 76(4):440-446. PubMed ID: 30688969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential role of anticonvulsants in the treatment of obsessive-compulsive and related disorders.
    Wang HR; Woo YS; Bahk WM
    Psychiatry Clin Neurosci; 2014 Oct; 68(10):723-32. PubMed ID: 24735021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic and Pharmacodynamic Evaluation of Intravenous Levetiracetam in Children With Epilepsy.
    Kim MJ; Yum MS; Yeh HR; Ko TS; Lim HS
    J Clin Pharmacol; 2018 Dec; 58(12):1586-1596. PubMed ID: 30052270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive, behavioural and sleep-related adverse effects on introduction of levetiracetam versus oxcarbazepine for epilepsy.
    Thelengana A; Shukla G; Srivastava A; Singh MB; Gupta A; Rajan R; Vibha D; Pandit AK; Prasad K
    Epilepsy Res; 2019 Feb; 150():58-65. PubMed ID: 30641352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depression in patients receiving pharmacotherapy for epilepsy: An audit in a tertiary care centre.
    Joshi R; Tripathi M; Gupta P; Goyal A; Gupta YK
    Pharmacol Rep; 2019 Oct; 71(5):848-854. PubMed ID: 31398575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.